INHBA and melanoma: Here, sustained INHBA expression or acute treatment of YUMM3.3 melanoma cells with recombinant Activin-A enhanced STAT1 phosphorylation by IFN-γ but interfered with cytostatic IFN-γ signaling in vitro without further upregulating IFN target genes.